Edison Scientific key facts
as of Oct 2026- Developer of an AI platform for scientific research and development intended to accelerate discovery across fields by giving every researcher access to an AI scientist.
- Edison Scientific is valued at approximately $255.0M as of Oct 2026, set at its seed round, Dec 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $70.0M across 1 recorded rounds; the latest was Seed Round ($70.0M) in Dec 2025.
- Notable investors include Spark Capital, Susa Ventures, Hawktail, Pillar VC, Triatomic Capital — 7 tracked in total.
- Edison Scientific has filed 1 Form D with the SEC, most recently Dec 2025 ($65.9M sold to 26 investors).
- Status: Privately Held (backing).
Valued at $255.0M at its seed round, Dec 2025. Nothing has traded since.
- ·Watch Edison Scientific: the Monday email on marks, rounds and moves
Edison Scientific funding rounds
1 roundsWho backs Edison Scientific
7Edison Scientific valuation
Edison Scientific was valued at $255 million at its seed round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Edison Scientific raised?
Edison Scientific has raised $70 million across 1 recorded round since 2025. The largest was a $70 million seed round in Dec 2025.
Edison Scientific has filed 1 Form D with the SEC, most recently in Dec 2025 ($65.9 million sold to 26 investors).
Edison Scientific investors
7 investors are on record for Edison Scientific, including Spark Capital, Susa Ventures, Hawktail and Pillar VC. By type, the record holds 4 venture capital firms and 1 private equity firm. The seed round in Dec 2025 drew 6 investors.
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Convergent Therapeutics ($280 million), Artios ($260 million) and Wugen ($245 million).
About Edison Scientific
Developer of an AI platform for scientific research and development intended to accelerate discovery across fields by giving every researcher access to an AI scientist. The company is built by scientists and engineers from leading institutions across physics, biology, chemistry and AI and identifies novel targets by synthesizing scientific literature, public data and its proprietary datasets, enabling researchers to complete research at unprecedented speed, from literature synthesis and data analysis to molecular design.
- Industry
- Drug Discovery
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 37
- Website
- edisonscientific.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.